Genome Editing Market is segmented By Type of Gene Editing Technique (CRISPR-Cas System, TALENs, Meganucleases, ZFNs, Other Techniques), By Type of Therapy (Cell Therapies, Gene Therapies, Other Therapies), By Gene Editing Approach (Gene Knock-Out Approaches, Gene Knock-In Approaches), By Gene Delivery Method(Ex-Vivo Delivery Methods, In-Vivo Delivery Methods), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.
Market Size in USD
CAGR12.6%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 12.6% |
Market Concentration | Medium |
Major Players | CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics, Beam Therapeutics, Caribou Biosciences |
The genome editing market is estimated to be valued at USD 3.90 Bn in 2024 and is expected to reach USD 8.95 Bn by 2031, growing at a compound annual growth rate (CAGR) of 12.6% from 2024 to 2031. The increasing prevalence of genetic disorders and cancer along with advancement in genome editing technologies is driving the growth of genome editing market.